Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction

Epithelial ovarian cancer (EOC) patients are generally diagnosed at an advanced stage, usually relapse after initial treatments, which include debulking surgery and adjuvant platinum-based chemotherapy, and eventually have poor 5-year survival of less than 50%. In recent years, promising survival be...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Ying-Cheng, Lin, Po-Han, Cheng, Wen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551835/
https://www.ncbi.nlm.nih.gov/pubmed/34722237
http://dx.doi.org/10.3389/fonc.2021.675972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551835/
https://www.ncbi.nlm.nih.gov/pubmed/34722237
http://dx.doi.org/10.3389/fonc.2021.675972

Ejemplares similares